Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis 2017 NCI 5F30CA180731-03 TCR Gene Transfer for Treating HCV-Associated Malignancies SPEAR, TIMOTHY LOYOLA UNIVERSITY CHICAGO IL $49,044
Hepatitis 2017 NIDA 5U01DA040381-02 Cohort Studies on HIV/AIDS and Substance Abuse in Miami BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $1,077,827
Hepatitis 2017 NIAID 5R01AI114748-03 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Hepatitis 2017 NHLBI 5R01HL119830-03 TTC39B in Metabolism TALL, ALAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $400,000
Hepatitis 2017 NIAAA 1U01AA024206-01A1 Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver disease FELDSTEIN, ARIEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $341,543
Hepatitis 2017 NIAID 5U01AI115711-03 Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant GRINSPOON, STEVEN MASSACHUSETTS GENERAL HOSPITAL MA $685,269
Hepatitis 2017 NIAID 5R01AI122669-02 Optimization of alpha-hydroxytropolones as novel inhibitors of the HBV RNaseH TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $440,118
Hepatitis 2017 NIAID 5UM1AI069476-10 The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit GRINSZTEJN, BEATRIZ FUNDACAO OSWALDO CRUZ BRAZIL $74,365
Hepatitis 2017 NIAID 5UM1AI069418-11 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $2,403,962
Hepatitis 2017 NIDA 5R01DA035146-05 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $550,788
Hepatitis 2017 NIMH 5K24MH097673-05 Midcareer Investigator Award in Patient-Oriented NeuroAIDS Research LETENDRE, SCOTT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $182,619
Hepatitis 2017 NIAID 5UM1AI069503-11 Terry Beirn CPCRA Clinical Trials Unit GORDIN, FRED GEORGE WASHINGTON UNIVERSITY DC $4,875,952
Hepatitis 2017 NIAID 5R01AI103440-05 A molecular basis for control of T cell memory HEDRICK, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $465,000
Hepatitis 2017 NIDA 5P30DA011041-20 5121 Infectious Diseases and Biomedical Core PERLMAN, DAVID NEW YORK UNIVERSITY NY $145,226
Hepatitis 2017 NIDDK 5K08DK099412-03 The role of macrophage migration inhibitory factor in autoimmune hepatitis ASSIS, DAVID YALE UNIVERSITY CT $152,874
Hepatitis 2017 NCI 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $100,000
Hepatitis 2017 NIAID 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $49,153,075
Hepatitis 2017 NIDA 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2017 NINDS 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Hepatitis 2017 OD 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $2,899,810
Hepatitis 2017 NIAID 5R01AI110577-03 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $453,213
Hepatitis 2017 NIDDK 5R01DK101941-03 Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients GARG, ABHIMANYU UT SOUTHWESTERN MEDICAL CENTER TX $364,500
Hepatitis 2017 NIAID 5UM1AI068632-11 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $20,201,111
Hepatitis 2017 NICHD 5UM1AI068632-11 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $4,567,863
Hepatitis 2017 OD 5UM1AI068632-11 LOC-IMPAACT Leadership Group NACHMAN, SHARON JOHNS HOPKINS UNIVERSITY MD $96,785
Hepatitis 2017 NIAID 5K08AI102761-05 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $195,063
Hepatitis 2017 NIAID 5R01AI078881-07 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $531,399
Hepatitis 2017 NIAID 5R01AI108765-04 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $514,747
Hepatitis 2017 NIAID 5R01AI104887-05 Control of Viral Pathogenesis by Regulation of 2-5A Levels WEISS, SUSAN UNIVERSITY OF PENNSYLVANIA PA $713,295
Hepatitis 2017 NIAID 5R01AI116943-02 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $545,126
Hepatitis 2017 NIAID 5R01AI085051-08 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $588,464
Hepatitis 2017 NIAID 5R37AI047365-18 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Hepatitis 2017 NIAID 5R01AI050611-13 A chicken model to study hepatitis E virus pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $392,874
Hepatitis 2017 NIAID 5U01AI115714-03 Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant STOCK, PETER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $621,488
Hepatitis 2017 NIDDK 5R01DK102597-03 NAFLD: Mechanisms and Treatments TIMCHENKO, NIKOLAI CINCINNATI CHILDRENS HOSP MED CTR OH $351,000
Hepatitis 2017 NIDDK 5K23DK095707-05 An Assessment of Liver Disease in HIV-infected and HIV/HBV Co-infected Tanzanians HAWKINS, CLAUDIA NORTHWESTERN UNIVERSITY AT CHICAGO IL $159,184
Hepatitis 2017 NCI 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $106,140
Hepatitis 2017 NIMHD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $209,615
Hepatitis 2017 NHLBI 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $286,781
Hepatitis 2017 NIAID 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $1,934,642
Hepatitis 2017 NICHD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $214,936
Hepatitis 2017 NIDA 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $53,072
Hepatitis 2017 NIDCD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $140,046
Hepatitis 2017 OD 5U01AI034994-24 Washington Women's Interagency HIV/AIDS Study KASSAYE, SEBLE GEORGETOWN UNIVERSITY DC $18,901
Hepatitis 2017 NIGMS 5R01GM116898-02 Function and mechanism of the HCV p7 channel and its therapeutic potential CHOU, JAMES HARVARD MEDICAL SCHOOL MA $463,975
Hepatitis 2017 NIDDK 5R01DK077704-09 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $337,125
Hepatitis 2017 NHLBI 5R01HL127174-02 Canonical & non-canonical regulation of the HDL receptor by PDZK1's PDZ domains KRIEGER, MONTY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $494,995
Hepatitis 2017 NIAID 5K08AI121348-02 Elucidating Mechanisms of Treatment Relapse for Interferon-Free HCV Therapy MEISSNER, ERIC MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $199,314
Hepatitis 2017 NIAID 5R01AI114630-03 Innate Immune Response to Hepatocyte Death CRISPE, IAN UNIVERSITY OF WASHINGTON WA $521,263
Hepatitis 2017 NHLBI 5K01HL121010-04 The Role of CD8+ T Cells In The Development of Nonalcoholic Fatty Liver Disease KENNEDY, ARION VANDERBILT UNIVERSITY TN $113,004
Hepatitis 2017 NIAAA 5P50AA011999-19 8467 Functional Dissection of EtOH-med Self-renew of Liver Tumor-Int Cells via TLR4 MACHIDA, KEIGO UNIVERSITY OF SOUTHERN CALIFORNIA CA $206,355
Hepatitis 2017 NIAAA 5U01AA021838-05 Transcriptomics of Liver in Alcoholic Hepatitis NORDEN-KRICHMAR, TRINA UNIVERSITY OF CALIFORNIA-IRVINE CA $255,735
Hepatitis 2017 NIAID 5R21AI122228-02 The impact of quasi-envelopment on hepatitis virus infection and immunity FENG, ZONGDI RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $224,250
Hepatitis 2017 NIDDK 5R01DK099055-04 Role of HIV-1 Nef in Acceleration of HCV-Mediated Liver Disease PARK, IN-WOO UNIVERSITY OF NORTH TEXAS HLTH SCI CTR TX $333,558
Hepatitis 2017 NIDDK 5R01DK108357-02 Tissue Responses to Metabolic Stress SCHAFFER, JEAN WASHINGTON UNIVERSITY MO $504,247
Hepatitis 2017 NIAID 5R21AI123718-02 Structure and Function of Hepatitis Delta Virus RNA-Protein Complexes CASEY, JOHN GEORGETOWN UNIVERSITY DC $194,375
Hepatitis 2017 NIAID 5R01AI116639-03 Hepatitis B virus vaccine escape mutants TONG, SHUPING RHODE ISLAND HOSPITAL RI $362,250
Hepatitis 2017 NIAID 5R01AI124006-02 Highly Attenuated Vesiculovirus-based Vectors as HBV Therapeutic Vaccines ROBEK, MICHAEL ALBANY MEDICAL COLLEGE NY $399,750
Hepatitis 2017 NIAID 5R01AI113923-03 Positive Immune-regulators During Chronic Viral Infections ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $459,066
Hepatitis 2017 NIAID 5R01AI105035-05 CD4+ T Cells in Acute Versus Chronic HCV Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $435,000
Hepatitis 2017 NIAID 5R01AI116868-02 Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans RIBEIRO, RUY LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $835,913
Hepatitis 2017 NIAAA 5K01AA024174-02 Connective tissue growth factor: an intriguing therapeutic target in alcoholic liver disease PI, LIYA UNIVERSITY OF FLORIDA FL $145,057
Hepatitis 2017 NIAAA 5K23AA023753-03 Understanding and intervening with heavy drinking among patients with HIV and HCV ELLIOTT, JENNIFER NEW YORK STATE PSYCHIATRIC INSTITUTE NY $199,800
Hepatitis 2017 NIDDK 5R01DK081817-07 HCV infection, cross-talk among liver cells, and liver disease progression RAY, RATNA SAINT LOUIS UNIVERSITY MO $340,875
Hepatitis 2017 NCI 5R01CA193244-07 Role of microR-122 in Hepatocarcinogenesis using Conditional Knockout Mice GHOSHAL, KALPANA OHIO STATE UNIVERSITY OH $365,750
Hepatitis 2017 NIDDK 5R01DK074932-11 LDL Receptor Related Protein-1 in Metabolic and Cardiovascular Disease HUI, DAVID UNIVERSITY OF CINCINNATI OH $355,500
Hepatitis 2017 NICHD 5R01HD041230-13 Prenatal Metabolic Programming of the Offspring DEVASKAR, SHERIN UNIVERSITY OF CALIFORNIA LOS ANGELES CA $319,550
Hepatitis 2017 NICHD 5R01HD075549-04 INNATE AND ADAPTIVE IMMUNITY TO HCV IN HUMAN PREGNANCY ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $321,437
Hepatitis 2017 NIDDK 1K08DK111397-01 Mentored Clinical Scientist Research Career Development (K08) research grant IBRAHIM, SAMAR MAYO CLINIC ROCHESTER MN $166,956
Hepatitis 2017 NIAID 5R01AI106005-04 Dissecting virus neutralizing determinants to guide HCV vaccine development LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $457,124
Hepatitis 2017 NIAID 1R01AI127463-01 Mechanisms of hepatic innate immune activation by HCV GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $556,742
Hepatitis 2017 NIAID 5R01AI123365-02 Structure and function of Hepacivirus envelope glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $625,625
Hepatitis 2017 NIDDK 1R01DK111678-01 Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis ANANIA, FRANK EMORY UNIVERSITY GA $470,998
Hepatitis 2017 NCI 1R01CA211794-01 Role of p62/SQSTM1 in obesity-induced liver cancer KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $739,996
Hepatitis 2017 NIAID 5R01AI095690-07 Micro-RNA 122 and Chronic Hepatitis C LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $380,000
Hepatitis 2017 NIDDK 5K08DK101754-04 New Hepatocyte Model Systems to study Hepatitis B Virus Infection SCHWARTZ, ROBERT WEILL MEDICAL COLL OF CORNELL UNIV NY $159,508
Hepatitis 2017 NIAID 5R01AI110358-03 Mechanisms of HCV Assembly YI, MINKYUNG UNIVERSITY OF TEXAS MED BR GALVESTON TX $387,500
Hepatitis 2017 NIDA 5R01DA027379-06 Economic Analysis of Rapid HIV and HCV Testing in Drug Abuse Treatment Programs SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $485,246
Hepatitis 2017 NIDA 5R01DA016065-14 HCV Disease Management in HIV-HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $706,777
Hepatitis 2017 NIDA 5U01DA036935-04 HIV Disease Outcomes in Drug Users in Clinical Practice MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $1,496,559
Hepatitis 2017 NIDA 5R01DA012568-19 INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS MEHTA, SHRUTI JOHNS HOPKINS UNIVERSITY MD $1,213,726
Hepatitis 2017 NCI 1UG3CA211551-01 Field-deployable platform for prognostic hepatic cancer screening in low-resource settings PORTER, MARC UNIVERSITY OF UTAH UT $399,914
Hepatitis 2017 NIAID 5R21AI124868-02 Risk of Liver Complications with HBV and HIV Viremia During Tenofovir-Based ART LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $244,615
Hepatitis 2017 NIAID 1R21AI127924-01 Ferret cell determinants of hepatitis C virus tropism EVANS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $253,347
Hepatitis 2017 NIAID 5R21AI119499-02 Hepatitis C virus polyprotein processing efficiency regulates infectious virus production TELLINGHUISEN, TIMOTHY SCRIPPS FLORIDA FL $85,215
Hepatitis 2017 NCI 5R01CA188305-03 Role of NCOA5 in hepatic steatosis and hepatocarcinogenesis XIAO, HUA MICHIGAN STATE UNIVERSITY MI $338,538
Hepatitis 2017 NIDDK 5R01DK091538-08 Ketone Body Metabolism and Integrated Metabolic Homeostasis CRAWFORD, PETER SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $251,416
Hepatitis 2017 NIAAA 1K99AA025386-01 Altered Treg differentiation in ALD: a novel role for anaphylatoxins C3a and C5a SMATHERS MCCULLOUGH, REBECCA CLEVELAND CLINIC LERNER COM-CWRU OH $110,939
Hepatitis 2017 NIAID 5R01AI065256-07 HIV Antiretroviral Therapy and Hepatic Injury SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $549,499
Hepatitis 2017 NIAID 5R01AI111970-04 Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models BROWN, ASHLEY UNIVERSITY OF FLORIDA FL $1,103,751
Hepatitis 2017 NIAID 1R21AI128325-01 Role of stem cell-derived T lymphocytes in chronic HBV infection SONG, JIM PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $232,950
Hepatitis 2017 NIDA 5K01DA036452-04 Social Networks of Youth who Misuse Prescription Opioids and Risk for HIV/HCV AL-TAYYIB, ALIA DENVER HEALTH AND HOSPITAL AUTHORITY CO $151,618
Hepatitis 2017 NIDDK 5F30DK108567-02 The role of SRSF1 in liver function and NASH ARIF, WAQAR UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $49,044
Hepatitis 2017 NCI 5R01CA168912-04 Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines HE, YUKAI AUGUSTA UNIVERSITY GA $320,588
Hepatitis 2017 NIAID 5R03AI119602-02 Identification of cellular factors that mediate HCV cell-to-cell spread UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $75,500
Hepatitis 2017 NIDDK 5P30DK097948-03 5072 Biorepository Core FIOCCHI, CLAUDIO CASE WESTERN RESERVE UNIVERSITY OH $221,916
Hepatitis 2017 NIDCR 5R03DE025652-02 Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease SLADE, GARY UNIV OF NORTH CAROLINA CHAPEL HILL NC $152,000
Hepatitis 2017 NIGMS 5P41GM103314-44 National Resource for Mass Spectrom of Biological Macromolecules CHAIT, BRIAN ROCKEFELLER UNIVERSITY NY $1,617,191
Hepatitis 2017 NIAID 5U19AI111825-04 7689 Effects of Persistent Innate Immune Activation on Vaccine Efficacy RICE, CHARLES ROCKEFELLER UNIVERSITY NY $599,480
Hepatitis 2017 NIAID 5U19AI109965-04 5821 Novel Pathogen Recognition Pathways and Control of Hepatitis A Virus LEMON, STANLEY UNIV OF NORTH CAROLINA CHAPEL HILL NC $407,732
Hepatitis 2017 NIAID 5U19AI109965-04 5825 Protein Purification and Biochemistry DUNCAN, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $328,213
Hepatitis 2017 NCI 5R01CA086978-14 Molecular mechanism of diet-induced carcinogenesis JACOB, SAMSON OHIO STATE UNIVERSITY OH $311,850
Hepatitis 2017 NIDA 5R01DA039072-03 Life Course Investigation of People Who Inject Drugs BOOTH, ROBERT UNIVERSITY OF COLORADO DENVER CO $551,935
Hepatitis 2017 NIDDK 5R01DK083283-07 AGEs/RAGE in Progressive NASH TOROK, NATALIE UNIVERSITY OF CALIFORNIA AT DAVIS CA $353,250
Hepatitis 2017 NIAID 5R01AI118916-02 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $507,805
Hepatitis 2017 NIDDK 5R01DK041876-29 Mechanisms of Liver Cell Injury GORES, GREGORY MAYO CLINIC ROCHESTER MN $381,899
Hepatitis 2017 NIAID 1R01AI123271-01A1 Development of an HTS Assay for Discovery of HBV cccDNA Inhibitors GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $404,744
Hepatitis 2017 NIDDK 5R01DK104956-03 Molecular Imaging of Liver Fibrosis FUCHS, BRYAN MASSACHUSETTS GENERAL HOSPITAL MA $532,832
Hepatitis 2017 NIAAA 5U01AA021898-05 ALCOHOLIC HEPATITIS PATHOGENESIS AS DETERMINED FROM HUMAN LIVER TISSUE ANALYSIS FRENCH, SAMUEL LA BIOMED RES INST/ HARBOR UCLA MED CTR CA $210,123
Hepatitis 2017 NIAAA 2R01AA017729-06 Innate immune signaling in alcoholic liver disease SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $376,875
Hepatitis 2017 NHLBI 2R01HL105704-06 Pan-Genomic Approaches for Comprehensive Blood Screening of Novel or Emerging Infectious Agents CHIU, CHARLES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $733,979
Hepatitis 2017 NIDDK 5R01DK097374-05 Subversion of hepatocyte phosphoinositide metabolism by hepatitis C virus TAI, ANDREW UNIVERSITY OF MICHIGAN MI $338,213
Hepatitis 2017 NIDDK 1R01DK112293-01 Fatty liver in HIV infected individuals GAWRIEH, SAMER INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $372,678
Hepatitis 2017 NIDDK 1R01DK112295-01 Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV NAGGIE, SUSANNA DUKE UNIVERSITY NC $400,209
Hepatitis 2017 NIDDK 5R01DK101773-03 Innate Defense Program against HCV SAITO, TAKESHI UNIVERSITY OF SOUTHERN CALIFORNIA CA $371,250
Hepatitis 2017 NIAID 5R01AI110762-02 Molecular Mechanisms of HBV cccDNA Formation GUO, HAITAO INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $392,500
Hepatitis 2017 NIDA 5R01DA025885-09 Sustainable HIV Risk Reduction Strategies for CJ Systems LEHMAN, WAYNE TEXAS CHRISTIAN UNIVERSITY TX $543,284
Hepatitis 2017 NIDDK 1K01DK109025-01A1 MyD88-dependent B cell dysfunction and autoimmunity during chronic liver disease THAPA, MANOJ EMORY UNIVERSITY GA $102,281
Hepatitis 2017 NIAID 5R01AI118933-02 Multimode Observation of Virus Capsid Assembly ZLOTNICK, ADAM INDIANA UNIVERSITY BLOOMINGTON IN $403,993
Hepatitis 2017 NIAAA 1K01AA024809-01A1 Role of Hepatocyte TLR4 in Alcohol-induced Steatohepatitis and Insulin Resistance JIA, LIN UT SOUTHWESTERN MEDICAL CENTER TX $149,472
Hepatitis 2017 NIDDK 1R13DK112338-01 Bile Acid Receptors as Signal Integrators in Liver and Metabolism JARVIS, THALE KEYSTONE SYMPOSIA CO $7,500
Hepatitis 2017 NIDDK 7R01DK100314-03 NAFLD Improvement after Bariatric Surgery: The role of bile acid signaling KOHLI, ROHIT CHILDREN'S HOSPITAL OF LOS ANGELES CA $482,124
Hepatitis 2017 NHLBI 1R35HL135833-01 Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men GINSBERG, HENRY COLUMBIA UNIVERSITY HEALTH SCIENCES NY $953,882
Hepatitis 2017 NIAID 5R03AI123689-02 Structural studies of the HBV ribonuclease H TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $75,750
Hepatitis 2017 NIDDK 5R01DK104735-03 TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITIS FINCK, BRIAN WASHINGTON UNIVERSITY MO $414,730
Hepatitis 2017 NIAAA 1R21AA024550-01A1 Role of sirtuin 6 in the protection of liver from the alcohol-induced injury DONG, X INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $224,250
Hepatitis 2017 NIDDK 5R01DK102883-03 HEPATOCYTE REMODELING BY HEPATITIS C VIRUS RANDALL, GLENN UNIVERSITY OF CHICAGO IL $350,489
Hepatitis 2017 NIAID 1U19AI118608-01A1 7025 Newborn cohorts to discover and validate biomarkers of neonatal vaccine immunogenicity LEVY, OFER BOSTON CHILDREN'S HOSPITAL MA $718,534
Hepatitis 2017 NIAID 1U19AI118608-01A1 7027 Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity STEEN, HANNO BOSTON CHILDREN'S HOSPITAL MA $159,300
Hepatitis 2017 NIAID 1U19AI118608-01A1 7028 Innovative OMIC integration to predict immunogenicity TEBBUTT, SCOTT UNIVERSITY OF BRITISH COLUMBIA CANADA $132,650
Hepatitis 2017 NIAID 1U19AI118608-01A1 7029 Immune status as a predictor of neonatal vaccine immunogenicity KOLLMANN, TOBIAS UNIVERSITY OF BRITISH COLUMBIA CANADA $132,631
Hepatitis 2017 NIAID 1U19AI118608-01A1 7030 In vitro modeling to characterize mechanisms of neonatal vaccine induced immune responses LEVY, OFER BOSTON CHILDREN'S HOSPITAL MA $190,972
Hepatitis 2017 NIAID 1U19AI128910-01 7049 Administrative Core: Core A HADDAD, ELIAS DREXEL UNIVERSITY PA $73,472
Hepatitis 2017 NIAID 1U19AI128910-01 7050 Clinical Core: Core B KALEEBU, PONTIANO UGANDA VIRUS RESEARCH INSTITUTE UGANDA $184,678
Hepatitis 2017 NIAID 1U19AI128910-01 7055 Investigating the impact of helminth infection on microbioma composition and innate immunity generated during HepB vaccination. SEKALY, RAFICK- CASE WESTERN RESERVE UNIVERSITY OH $287,394
Hepatitis 2017 NIAID 5R01AI085087-07 Role of Lipids in Hepatitis C Virus Maturation SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $387,500
Hepatitis 2017 NIDDK 5K08DK101757-04 Optimization and control of hepatocyte activity via biofunctional modification WERTHEIM, JASON NORTHWESTERN UNIVERSITY AT CHICAGO IL $161,748
Hepatitis 2017 NIAID 1R01AI120622-01A1 RESUBMISSION -R01 AI120622 –Restoration of Immunity and Function with DAA Treatment in HCV infection ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $388,750
Hepatitis 2017 NIDDK 5R01DK108743-02 Control of stellate cells-driven liver cancer by the p62/NBR1 adapters MOSCAT, JORGE SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $433,352
Hepatitis 2017 NIAAA 5R01AA011576-16 Alcohol and Monocyte Signaling SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $376,875
Hepatitis 2017 NIDA 5K24DA035684-04 Treatment outcomes and comorbidity in HIV-infected IDU LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $165,901
Hepatitis 2017 NIDA 5R21DA041953-02 Modeling HCV/HIV transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs ALTICE, FREDERICK YALE UNIVERSITY CT $258,852
Hepatitis 2017 NIAID 5U19AI123861-02 6292 Administrative Core LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $174,367
Hepatitis 2017 NIAID 5U19AI123861-02 6293 Antibody responses to HCV vaccine antigens in infection and vaccination LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $424,742
Hepatitis 2017 NIAID 5U19AI123861-02 6294 Novel HCV vaccine antigens targeting conserved neutralizing epitopes ZHU, JIANG SCRIPPS RESEARCH INSTITUTE CA $319,627
Hepatitis 2017 NCI 5R01CA186566-03 Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC) HASSAN, MANAL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $655,272
Hepatitis 2017 NINR 5F31NR016200-02 Nurse Case Management to Improve Hepatitis C Linkage to Care and Treatment in HIV Coinfection STARBIRD, LAURA JOHNS HOPKINS UNIVERSITY MD $36,559
Hepatitis 2017 NIGMS 5F31GM119345-02 Structure-based design of robust cross-genotypic NS3/4A protease inhibitors that avoid resistance MATTHEW, ASHLEY UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $31,207
Hepatitis 2017 NIAID 5U19AI057229-14 7617 The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination DAVIS, MARK STANFORD UNIVERSITY CA $508,137
Hepatitis 2017 NIDDK 5R01DK095862-05 Protective role of adenosine 2A receptor in NAFLD WU, CHAODONG TEXAS A&M AGRILIFE RESEARCH TX $317,242
Hepatitis 2017 NIDDK 5R01DK102850-03 Mechanisms underlying Hepatoprotective Roles of Sestrin2 LEE, JUN HEE UNIVERSITY OF MICHIGAN MI $348,750
Hepatitis 2017 NIAID 5R01AI120733-02 The Impact of HCV Infection on Bone Turnover, Density, and Strength BROWN, TODD JOHNS HOPKINS UNIVERSITY MD $762,061
Hepatitis 2017 NIAID 5U19AI088791-07 6463 Administrative Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $35,337
Hepatitis 2017 NIAID 5U19AI088791-07 6464 Scientific Core COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $266,709
Hepatitis 2017 NIAID 5U19AI088791-07 6465 Mechanisms driving breadth of HCV neutralization during repeated control of acute infection in humans BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $136,636
Hepatitis 2017 NIAID 5U19AI088791-07 6466 Mechanisms of T cell control in repeated HCV infection and innate immune responses that drive them COX, ANDREA JOHNS HOPKINS UNIVERSITY MD $161,104
Hepatitis 2017 NIAID 5U19AI088791-07 6467 Project 3: To define the genetic identity of infecting, superinfecting, and reinfecting strains of HCV and the dynamics of virus elimination, replacement or persistence SHAW, GEORGE UNIVERSITY OF PENNSYLVANIA PA $152,632
Hepatitis 2017 NIAID 1R44AI129232-01 A Cytomegalovirus-based therapeutic vaccine for chronic hepatitis B BRUENING, ERIC TOMEGAVAX, INC. OR $297,434
Hepatitis 2017 NIEHS 5F30ES025099-03 Xenobiotic Receptors Modulate PCB-induced Steatohepatitis CLAIR, HEATHER UNIVERSITY OF LOUISVILLE KY $49,044
Hepatitis 2017 NIDDK 1F30DK112514-01 Hepatitis C virus cell entry host factor requirements and mechanisms CHAMBERS, MATTHEW ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $43,884
Hepatitis 2017 NIAID 5U19AI109662-04 7133 Haploid genetic screen to identify host genes required for RNA virruses GLENN, JEFFREY STANFORD UNIVERSITY CA $426,597
Hepatitis 2017 NIAID 5U19AI109662-04 7134 Computation and Repurposing to identfy antivirals directed against dominant PANDE, VIJAY STANFORD UNIVERSITY CA $722,109
Hepatitis 2017 NCI 5R01CA190678-03 Mechanisms of obesity-induced hepatocarcinogenesis CHUNG, FUNG-LUNG GEORGETOWN UNIVERSITY DC $380,255
Hepatitis 2017 FIC 5D43TW009771-04 HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis. MANABE, YUKARI JOHNS HOPKINS UNIVERSITY MD $289,221
Hepatitis 2017 NIDDK 1F31DK112607-01 A critical role for group 3 innate lymphocytes in hepatitis B virus pathogenesis JESPERSEN, JILLIAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $38,402
Hepatitis 2017 NIEHS 2P42ES010337-16 5191 Research Translation Core: Extending the Reach of Exposure Science and Technology That Improves the Detection and Remediation of Hazardous Substances PEZZOLI, KEITH UNIVERSITY OF CALIFORNIA SAN DIEGO CA $133,185
Hepatitis 2017 NIEHS 2P42ES010337-16 5192 Community Engagement and Urban Agriculture: Addressing Concerns About Toxicants in Soil, Water and Plants PEZZOLI, KEITH UNIVERSITY OF CALIFORNIA SAN DIEGO CA $133,182
Hepatitis 2017 NIEHS 2P42ES010337-16 5193 Project 1: Control of Toxin Obesity Induced Liver Fibrosis by B Cells KARIN, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $299,658
Hepatitis 2017 NIEHS 2P42ES010337-16 5194 Project 2: Nuclear Receptor Mediated Epigenetic and Immune Cell Changes in Liver Fibrosis Resulting From Toxicant Exposure EVANS, RONALD SALK INSTITUTE FOR BIOLOGICAL STUDIES CA $360,142
Hepatitis 2017 NIEHS 2P42ES010337-16 5195 Project 3: Molecular and Microbial Mechanisms Leading to Triclosan Induced Liver Fibrosis TUKEY, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $299,660
Hepatitis 2017 NIEHS 2P42ES010337-16 5196 Project 4: The Role of Reactive Oxygen Species and the Microbiome in Toxicant Induced Liver Fibrosis BRENNER, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $299,661
Hepatitis 2017 NIDDK 5F32DK109658-02 Dissecting the role of hepatic macrophages in progressive NASH KRUGER, ANNIE MASSACHUSETTS GENERAL HOSPITAL MA $63,078
Hepatitis 2017 NIAAA 5P50AA024333-02 8232 Core C: Clinical Core MCCULLOUGH, ARTHUR CLEVELAND CLINIC LERNER COM-CWRU OH $168,150
Hepatitis 2017 NIAAA 5P50AA024333-02 8234 Project 1: Gut Microbial Metabokites as Drivers of Ethanol-Induced Liver Injury BROWN, JONATHAN CLEVELAND CLINIC LERNER COM-CWRU OH $249,637
Hepatitis 2017 NIAAA 5P50AA024333-02 8237 Project 4: Innate Immunity and Cell Death in ALD NAGY, LAURA CLEVELAND CLINIC LERNER COM-CWRU OH $249,635
Hepatitis 2017 NIDDK 5R01DK101579-05 Physiology of Lipid Droplets and Triglyceride Storage FARESE, ROBERT HARVARD SCHOOL OF PUBLIC HEALTH MA $497,727
Hepatitis 2017 NIAID 1R21AI124672-01A1 Defining approaches for improving HID and HPD compounds as HBV RNaseH antagonists TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $227,250
Hepatitis 2017 NIAID 5R01AI116269-03 Immune correlates of acute HBV recovery with and without HIV THIO, CHLOE JOHNS HOPKINS UNIVERSITY MD $649,053
Hepatitis 2017 NIDA 5P30DA040500-03 6227 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Admin Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $341,346
Hepatitis 2017 NIDA 5P30DA040500-03 6228 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Methodology Core) SCHACKMAN, BRUCE WEILL MEDICAL COLL OF CORNELL UNIV NY $264,051
Hepatitis 2017 NIDA 5P30DA040500-03 6229 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (HCV + HIV Core) LINAS, BENJAMIN BOSTON MEDICAL CENTER MA $332,780
Hepatitis 2017 NIDA 5P30DA040500-03 6230 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Dissemination Core) MEISEL, ZACHARY UNIVERSITY OF PENNSYLVANIA PA $351,744
Hepatitis 2017 NIDA 5P30DA040500-03 6231 Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (Pilot Training Core) ADEN, BRANDON WEILL MEDICAL COLL OF CORNELL UNIV NY $77,061
Hepatitis 2017 NIAID 5K23AI118584-03 TRIPAI: An innovative way to improve the health of infants by including fathers during prenatal care YEGANEH, NAVA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $202,427
Hepatitis 2017 NCI 5U54CA193417-03 7366 Project 1: Mechanisms of Stiffening in Liver Cancer DISCHER, DENNIS UNIVERSITY OF PENNSYLVANIA PA $346,854
Hepatitis 2017 NIAID 5R01AI071068-12 Acute/chronic limitations to transcriptional RNAi therapies for infectious and other liver diseases KAY, MARK STANFORD UNIVERSITY CA $481,343
Hepatitis 2017 NIAID 5R01AI087925-07 Molecular determinants of hepatitis C virus assembly LINDENBACH, BRETT YALE UNIVERSITY CT $418,750
Hepatitis 2017 NCI 5P01CA022443-40 6854 Mechanisms of Hepatitis B Virus Replication LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $322,415
Hepatitis 2017 NCI 5P01CA022443-40 6867 Instrumentation LOEB, DANIEL UNIVERSITY OF WISCONSIN-MADISON WI $68,077
Hepatitis 2017 NCI 5P01CA022443-40 6868 Virus Production MERTZ, JANET UNIVERSITY OF WISCONSIN-MADISON WI $101,040
Hepatitis 2017 NIAID 5R01AI097552-04 Role of Lipid Droplets in Hepatitis C Virus Infection OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $477,500
Hepatitis 2017 NCI 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $24,025
Hepatitis 2017 NIMHD 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $9,505
Hepatitis 2017 NHLBI 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $16,637
Hepatitis 2017 NIA 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $2,805
Hepatitis 2017 NIAID 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $104,911
Hepatitis 2017 NICHD 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $7,595
Hepatitis 2017 NIDA 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $11,871
Hepatitis 2017 NIDDK 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $6,364
Hepatitis 2017 NIGMS 5P30AI036219-23 5313 Clinical Services Core D RODRIGUEZ, BENIGNO CASE WESTERN RESERVE UNIVERSITY OH $6,364
Hepatitis 2017 NIDA 5R01DA033862-05 Effect of structural interventions on substance use and HIV/HCV risk among rural PWUD HAVENS, JENNIFER UNIVERSITY OF KENTUCKY KY $555,961
Hepatitis 2017 NIAAA 5F31AA024960-02 A pivotal role for junctional adhesion molecule-A in alcoholic liver injury CHOPYK, DANIEL EMORY UNIVERSITY GA $49,044
Hepatitis 2017 NIDDK 5R01DK109823-02 HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression TIEN, PHYLLIS NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $692,364
Hepatitis 2017 NCI 5R01CA198103-02 ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma KAUFMAN, RANDAL SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $707,261
Hepatitis 2017 NIDA 5U01DA036267-05 MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) GORBACH, PAMINA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $1,488,949
Hepatitis 2017 NIGMS 5R01GM105414-05 Genotypic& phenotypic characterization of the HCV polymerase (NS5B) in HIV BLACKARD, JASON UNIVERSITY OF CINCINNATI OH $299,434
Hepatitis 2017 NCI 5U01AI069918-12 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $502,095
Hepatitis 2017 NIAID 5U01AI069918-12 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $2,240,694
Hepatitis 2017 NIDA 5U01AI069918-12 North American AIDS Cohorts Collaboration on Research and Design (NAACCORD) Renewal MOORE, RICHARD JOHNS HOPKINS UNIVERSITY MD $299,953
Hepatitis 2017 NIDA 5R01DA036514-04 Evaluating a Microfinance Intervention for High Risk Women in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $664,795
Hepatitis 2017 NCI 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $260,000
Hepatitis 2017 NIAID 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $1,309,336
Hepatitis 2017 NICHD 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $325,000
Hepatitis 2017 NIDA 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $100,000
Hepatitis 2017 NIDDK 5P01DK057751-17 5096 Expression of the type 3 InsP3 receptor in the injured hepatocyte: mechanisms and effects NATHANSON, MICHAEL YALE UNIVERSITY CT $350,033
Hepatitis 2017 NCI 5U01AI069919-12 IeDEA West Africa Renewal 3 DABIS, FRANCOIS ADERA FR $225,000
Hepatitis 2017 NIAID 5U01AI069919-12 IeDEA West Africa Renewal 3 DABIS, FRANCOIS ADERA FR $274,211
Hepatitis 2017 NICHD 5U01AI069919-12 IeDEA West Africa Renewal 3 DABIS, FRANCOIS ADERA FR $250,000
Hepatitis 2017 NCATS 5KL2TR001441-03 UTMB Clinical and Translational Science Award AMEREDES, BILL UNIVERSITY OF TEXAS MED BR GALVESTON TX $313,812
Hepatitis 2017 NIDA 1R01DA043409-01 Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention HERBECK, JOSHUA UNIVERSITY OF WASHINGTON WA $668,778
Hepatitis 2017 NIAID 1R21AI124923-01A1 Immune correlates of HAART-mediated spontaneous control of chronic HCV infection OSBURN, WILLIAM JOHNS HOPKINS UNIVERSITY MD $245,282
Hepatitis 2017 NIDA 5R01DA026770-08 Early-Stage Chronic Kidney Disease in HIV-infected Individuals LUCAS, GREGORY JOHNS HOPKINS UNIVERSITY MD $620,459
Hepatitis 2017 NIGMS 5SC1GM111158-03 Biological Studies of alpha-Hydroxytropolones MURELLI, RYAN BROOKLYN COLLEGE NY $392,500
Hepatitis 2017 NIDA 1R03DA041892-01A1 Migrant Puerto Rican PWID: The Influence of Acculturation and Enculturation on HIV and HCV Risk Behaviors GELPI-ACOSTA, CAMILA NATIONAL DEVELOPMENT & RES INSTITUTES NY $159,932
Hepatitis 2017 NHLBI 1K23HL133358-01A1 Elucidating Hepatitis C Infection as a Risk Factor for Coronary Heart Disease in HIV-Infected Patients BAGCHI, SHASHWATEE UNIVERSITY OF MARYLAND BALTIMORE MD $182,354
Hepatitis 2017 NIDA 5R37DA013806-18 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $733,577
Hepatitis 2017 NIAAA 5P50AA024337-02 8302 Role of Dietary Fat in Alcoholic Liver Disease MCCLAIN, CRAIG UNIVERSITY OF LOUISVILLE KY $68,290
Hepatitis 2017 NIDDK 5R01DK106244-02 Hepatitus C virus-induced inflammasome and lipid metabolism WARIS, GULAM ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $351,000
Hepatitis 2017 NHGRI 5RM1HG009038-02 Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease GELLER, GAIL JOHNS HOPKINS UNIVERSITY MD $1,027,331
Hepatitis 2017 NIMH 5R01MH085538-08 Hepatitis C Drives Neuropathogenesis in HIV/HCV Coinfection Patients PULLIAM, LYNN NORTHERN CALIFORNIA INSTITUTE/RES/EDU CA $486,540
Hepatitis 2017 NIDA 5R34DA039333-03 Hepatitis C Treatment As Prevention Pilot Study with Ledipasvir-Sofosbuvir Among People Actively Injecting Drugs (TasP-C Pilot) COFFIN, PHILLIP PUBLIC HEALTH FOUNDATION ENTERPRISES CA $114,015
Hepatitis 2017 NIDA 5R01DA040499-03 Antiviral pharmacology and adherence in drug users KISER, JENNIFER UNIVERSITY OF COLORADO DENVER CO $521,567
Hepatitis 2017 NCCIH 5R01AT001576-15 Role of SAMe in Pathogenesis and Treatment of Non-Alcholic Fatty Liver Disease LU, SHELLY CEDARS-SINAI MEDICAL CENTER CA $295,647
Hepatitis 2017 NIAID 5R01AI125401-02 Developmental regulation of HBV biosynthesis by FoxA and DNA methylation MCLACHLAN, ALAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,750
Hepatitis 2017 NIDDK 5R01DK106348-03 In Vivo 2H/13C Metabolic Flux Analysis of NASH Pathogenesis YOUNG, JAMEY VANDERBILT UNIVERSITY TN $347,358
Hepatitis 2017 NIMHD 5U01MD010614-02 Increasing Uptake of Evidence Based Screening Services though a CHW-led multi-modality program: The South Florida Center for Reducing Health Disparities CARRASQUILLO, OLVEEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $487,186
Hepatitis 2017 NIDA 5K02DA035116-05 Social Networks and HIV Risk Behaviors of Special Populations of Drug Users OSER, CARRIE UNIVERSITY OF KENTUCKY KY $115,827
Hepatitis 2017 NIAAA 5U01AA021856-05 Microbiome as Therapeutic Target in Alcoholic Hepatitis SCHNABL, BERND UNIVERSITY OF CALIFORNIA SAN DIEGO CA $427,499
Hepatitis 2017 NIDA 5R01DA022177-11 Opioids, HIV/HCV and host cell innate immunity HO, WENZHE TEMPLE UNIV OF THE COMMONWEALTH PA $271,250
Hepatitis 2017 OD 5R01OD011095-25 Modeling Viral and T Lymphocyte Dynamics PERELSON, ALAN LOS ALAMOS NAT SECTY-LOS ALAMOS NAT LAB NM $444,412
Hepatitis 2017 NIAAA 5U01AA021912-05 Targeting DAMPs in Alcoholic Hepatitis SCHWABE, ROBERT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $372,541
Hepatitis 2017 NIAAA 5R01AA021133-05 RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse PROESCHOLD-BELL, RAE JEAN DUKE UNIVERSITY NC $742,809
Hepatitis 2017 NCI 5R21CA202396-02 The role of IL-27 cytokine in hepatocellular carcinoma (HCC) development KOLTSOVA, EKATERINA RESEARCH INST OF FOX CHASE CAN CTR PA $199,013
Hepatitis 2017 NIAID 5R01AI113267-05 Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors GUO, JU-TAO BARUCH S. BLUMBERG INSTITUTE PA $511,927
Hepatitis 2017 NIAID 5K23AI108355-03 Quantitative Pharmacology for Accelerating Drug Development for HIV/HCV Co-Infected Patients VENUTO, CHARLES UNIVERSITY OF ROCHESTER NY $149,818
Hepatitis 2017 NIAAA 5R37AA009300-22 Lipid Aldehyde and Ethanol Induced Liver Damage PETERSEN, DENNIS UNIVERSITY OF COLORADO DENVER CO $481,789
Hepatitis 2017 NIAID 5U19AI082630-09 7590 Restoration of Innate Immunity with Viral Cure CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $480,820
Hepatitis 2017 NIAID 5U19AI082630-09 7591 Mechanisms of Restoring T Cell Immunity after Cure of Chronic Viral Infection LAUER, GEORG MASSACHUSETTS GENERAL HOSPITAL MA $483,362
Hepatitis 2017 NIAID 5U19AI082630-09 7592 Epigenetic Plasticity of HCV-Specific CD8 T Cells after Antiviral Therapy HAINING, WILLIAM DANA-FARBER CANCER INST MA $410,216
Hepatitis 2017 NIAID 5U19AI082630-09 7593 Induction and Recovery of T Cells after Cure of Chronic Viral Infection KLENERMAN, PAUL UNIVERSITY OF OXFORD UK $248,236
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer